top of page
Technology

TECHNOLOGY

At MindGuide we use immersive technologies including next generation virtual reality and augmented reality to reduce anxiety, treat phobias and increase stress resilience.

The technology is rigorously tested in scientific studies and clinical trials at the University of Basel.

PROJECTS

Reduce specific phobias, such as fear of heights or fear of animals

To be published soon

Reduce social fears, such as fear of public speaking

To be published soon

Increase stress resilience and well-being

Development on request

MindGuide offers tailored applications for hospitals and companies

PROJECTS
ABOUT

ABOUT

MindGuide is a Division of GeneGuide, a spin-off company of the University of Basel, founded 2013, and directed by the two founders

de Quervain.jpg

Dominique de Quervain, M.D., is a full Professor at the Faculty of Medicine & Faculty of Psychology and Director of the Division of Cognitive Neuroscience, University of Basel, Switzerland.

Papas.png

Andreas Papassotiropoulos, M.D., is a full Professor at the Faculty of Medicine & Faculty of Psychology and Director of the Division of Molecular Neuroscience, University of Basel, Switzerland.

Andreas Papassotiropoulos and Dominique de Quervain share more than 18 years of scientific collaboration. They have published numerous milestone publications in leading journals, such as Nature, Science, Cell, Nature Neuroscience, Nature Communications, Nature Human Behaviour, Neuron, and PNAS on human cognitive and emotional functions, including clinical trials. Click here for the full publication list.

MindGuide_logo.png

GeneGuide AG

MindGuide

Birmannsgasse 8

4055 Basel

Switzerland


 

email: geneguide@brainscience.ch     

phone: +41 61 207 02 38   

fax: +41 61 207 02 41         
 

Copyright © MindGuide 2013-2023

bottom of page